Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial

BACKGROUND: Patients in chronic somatic diseases are often accompanied with depression and anxiety, remission of which may be observed in the third or fourth week after applying common antidepressant medications. We investigate the efficacy and safety of sertraline plus deanxit on patients with depr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Limin, Zhong, Zhuoyuan, Hu, Jingyang, Rong, Xiaoming, Liu, Jun, Xiao, Songhua, Liu, Zhonglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403889/
https://www.ncbi.nlm.nih.gov/pubmed/25879863
http://dx.doi.org/10.1186/s12888-015-0449-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403889/
https://www.ncbi.nlm.nih.gov/pubmed/25879863
http://dx.doi.org/10.1186/s12888-015-0449-2

Ejemplares similares